author index for volume bennett, james€¦ · abou-donia, mohamed b.seemcphai! and rosen, 590...
TRANSCRIPT
MOLECULAR PHARMACOLOGY, 12, 1106-1114
Copyright © 1976 by Academic Press, Inc.All rights or reproduction in any form reserved.
AUTHOR INDEX FOR VOLUME 12
A
Abou-Donia, Mohamed B. See McPhai! and Rosen,
590
Abrahams, Sanders L. , Northup, John K. and Man-sour, Tag E. Adenosine Cyclic 3’ ,5’-Mono-phosphate in the Liver Fluke, Fascioki he-
patica. I. Activation of Adenylate Cyclase by
5-Hydroxytryptamine, 49
Abrahams, Sanders L. See Gentleman and Man-
sour, 59
Akera, Tai, Ku, David, Tobin, Thomas and Brody,Theodore M. The Complexes of0uabain with
Sodium- and Potassium-Activated Adenosine
Triphosphatase Formed with Various Li-
gands: Relationship to the Complex Formed
in the Beating Heart, 101
Albuquerque, E. X., Brookes, N., Onur, R. and
Warnick, J. E. Kinetics of Interaction of Ba-
trachotoxin and Tetrodotoxin on Rat Dia-
phragm Muscle, 82
Alderfer, James L. See Arya, Carter and Ts’o, 234
Alderfer, James L. See Ts’o, Levy, Marsha!!,
O’Ma!ley, Horoszewicz and Carter, 299
Alderfer, James L. See Carter, O’Malley, Beeson,
Cunnington, Kelvin, Vere-Hodge and Ts’o,
440
Allan, Paula W. See Bennett, Hill, Thomas and
Carpenter, 242
Ari#{235}ns, E. J. See Lien and Rodrigues de Miranda,
598
Arin#{231},Emel. See Philpot, 483
Arya, S. K., Carter, William A., Alderfer, James L.and Ts’o, Paul 0. P. Inhibition ofSynthesis ofMurine Leukemia Virus in Cultured Cells by
Polyribonucleotides and Their 2’-O-Alkyl De-
rivatives, 234
Arya, S. K., Helser, T. L., Carter, W. A. and Ts’o,P. 0. P. Polyxanthylic and Polyguanylic Acid
Inhibition of Murine Leukemia Virus Activi-
ties, 844
B
Baguley, Bruce C. See Cain and Wilson, 1027
Barker, L. A. See Collier and Mittag, 340
Bartels-Bernal, Eva, Rosenberry, Terrone L. and
Chang, Hai Won. A Membrane ActivationCycle Induced by Sulfhydryl Reagents after
Affinity Labeling of the Acetyicholine Recep-
tor of Electroplax, 813
Beeson, Malcolm. See Carter, O’Malley, Cunning-
1106
ton, Kelvin, Vere-Hodge, Alderfer and Ts’o,
440
Belcher, Daniel H. See Kamataki and Neal, 921
Bennett, James P., Jr. and Snyder, Solomon H.Serotonin and Lysergic Acid Diethylamide
Binding in Rat Brain Membranes: Relation-
ship to Postsynaptic Serotonin Receptors, 373
Bennett, L. Lee, Jr., Allan, Paula, W., Hill, DonaldL. , Thomas, H. Jeanette and Carpenter, JeanW. Metabolic Studies with an a-Nucleoside,9-a-D-Arabinofuranosyl-8-azaadenine, 242
Bettis, Carol J. See Wirth and Nelson, 759
Bina-Stein, Minou and Tritton, Thomas R. Aurin-
tricarboxylic Acid is a Nonspecific Enzyme
Inhibitor, 191
Birkett, D. J. See Sud!ow and Wade, 1052
Bittner, Mary A. and Ruddon, Raymond W. Induc-
tion and Decay of Aryl Hydrocarbon Hydrox-
ylase Activity in Mouse 3T3 Cells, 966
Bl#{225}ha, Karel. See Cort, Fri#{235},Carlsson, Gillessen,
Bystricky, �kopkova, Gut, Studer and
Mulder, 313
Blisard, Karen S. See Diamond, 688
Bloom, F. E. See Nathanson, 390
Boadle-Biber, Margaret C. See Morgenroth and
Roth, 41
Boggs, J. M., Yoong, T. and Hsia, J. C. Site and
Mechanism of Anesthetic Action. I. Effect of
Anesthetics and Pressure on Fluidity of Spin-
Labeled Lipid Vesicles, 127
Boggs, J. M., Roth, S. H., Yoong, T., Wong, E. and
Hsia, J. C. Site and Mechanism of AnestheticAction. II. Pressure Effect on the Nerve Con-
duction-Blocking Activity ofa Spin Label An-
esthetic, 136
Bourne, Henry R. See Melmon, Weinstein, Poon,
Shearer and Castagnoli, 701
Bourne, Henry R. Seelnsel, Maguire, Gilman, Cof-
fino and Melmon, 1062
Boyd, Helen and Martin, T. J. Changes in Catechol-
amine- and Glucagon-Responsive Adenylate
Cyclase Activity in Preneoplastic Rat Liver,195
Brody, Theodore M. See Akera, Ku and Tobin, 101
Brookes, N. See Albuquerque, Onur and Warnick,
82
Brostrom, Charles 0. See Browning and Groppi, 32Browning, Edward T., Brostrom, Charles 0. and
Groppi, Vincent E., Jr. Altered AdenosineCyclic 3’,5’-Monophosphate Synthesis and
Degradation by C-6 Astrocytoma Cells Fol-
AUTHOR INDEX
lowing Prolonged Exposure to Norepineph-
rine, 32
800
1107
Burghardt, Charles R. See Sheppard and Teitel, 854
Burt, David R., Creese, Ian and Snyder, SolomonH. Binding Interactions of Lysergic Acid Di-ethylamide and Related Agents with Dopa-
mine Receptors in the Brain, 631
Burt, David R., Creese, Ian and Snyder, SolomonH. Properties of [3H]Haloperidol and[3H]Dopamine Binding Associated with Do-pamine Receptors in Calf Brain Membranes,
Butcher, Fred R., Rudich, Lynn, Emler, Carol andNemerovski, Mark. Adrenergic Regulation ofCyclic Nucleotide Levels, Amylase Release,
and Potassium Efflux in Rat Parotid Gland,
862
Butler, K. W. See Neal, Polnasek and Smith, 144
Bylund, David B. and Snyder, Solomon H. Beta
Adrenergic Receptor Binding in Membrane
Preparations from Mammalian Brain, 568
Bystricky, SlavomIr. See Cort, Fri#{235},Carlsson, Gil-
lessen, �kopkova, Gut, Studer, Mulder and
Bldha, 313
C
Cain, Bruce F., Wilson, William Robert and Bagu-ley, Bruce C. Structure-Activity Relation-
ships for Thiolytic Cleavage Rates of Antitu-
mor Drugs in the 4’-(9-Acridinylamino)-
methanesulfonanilide Series, 1027
Cann, John R. See Hinman, 769
Carlsson, Lars. See Cort, Fri#{235},Gillessen, Bystrick?,
�kopkova, Gut, Studer, Mulder and Bldha,
313Caron, Marc G. See Mukherjee, Mullikin and Lef-
kowitz, 16
Carpenter, David 0., Greene, Lloyd A., Sham, Wil-ham and Vogel, Zvi. Effects of Eserine andNeostigmine on the Interaction of a-Bungaro-
toxin and Aplysia Acetylcholine Receptors,
999
Carpenter, Jean W. See Bennett, Allan, Hill and
Thomas, 242
Carter, William A. See Arya, Alderfer and Ts’o, 234
Carter, William A., O’Malley, Judith, Beeson, Mal-colm, Cunnington, Peter, Kelvin, Alan,Vere-Hodge, Anthony, Alderfer, James L.
and Ts’o, Paul 0. P. An Integrated and Com-parative Study of the Antiviral Effects andOther Biological Properties of the Polyino-
sinic � Polycytidylic Acid Duplex and Its Mis-
matched Analogues. III. Chronic Effects andImmunological Features, 440
Carter, W. A. See Arya, Helser and Ts’o, 844
Castagnoli, Neal, Jr. See Melmon, Weinstein,
Bourne, Poon and Shearer, 701
Chang, Hai Won. See Bartels-Bernal and Rosen-
berry, 813
Changeux, J.-P. See Kato, 92
Chan-Stier, Christine. See Minkel and Petering,
1036
Chen, Wen-Sherng. See Maglothin and Wilson, 658
Chignell, Cohn F. See Wee, Sinha and Taylor, 667
Chignell, Cohn F. See Wee, Feldmann and Tanis,
832
Chignell, Cohn F. See Weiland, Georgia, Wee and
Taylor, 1091
Chou, David. See Weinstein, Johnson, Kang and
Green, 738
Chuang, De-Maw and Costa, Erminio. Trans-syn-aptic Regulation of Ribonucleic Acid Biosyn-
thesis in Rat Adrenal Medulla, 514
Chytil, Frank. See Moses, Spelsberg and Korinek,
731
Coffino, Philip. See Insel, Maguire, Gilman,
Bourne, and Me!mon, 1062
Collier, B., Barker, L. A. and Mittag, T. W. TheRelease of Acetylated Choline Analogues by aSympathetic Ganglion, 340
Colquhoun, D. and Rang, H. P. Effects of Inhibitorson the Binding of lodinated a-Bungarotoxin
to Acetylcholine Receptors in Rat Muscle, 519
Cort, Joseph H., Frk, Ivo, Carlsson, Lars,Gillessen, Dieter, Bystricky, SlavomIr,�kopkova, Jana, Gut, Vladimir, Studer, Rolf0., Mulder, Jan L. and Bl#{225}ha,Karel. Biologi-
cal and Chiroptical Sequelae of Graded Alkyl
Substitutions in the Vasopressin Ring, 313
Costa, E. See Kurosawa and Guidotti, 420
Costa, Elizabeth. See Costa, Manen, Sipes and Rus-
sell, 871
Costa, Erminio. See Chuang, 514
Costa, Max, Costa, Elizabeth R., Manen, Carol-Ann, Sipes, I. Glenn and Russell, Diane Had-
dock. Adenosine Cyclic 3’,S’-Monophosphate-Dependent Protein Kinase and Ornithine De-carboxylase Involvement in the Induction of
Cytochrome P-450 and Hepatic Hypertrophy,
871
Coutinho, Claude B. See Lucek, 612
Creese, Ian. See Burt and Snyder, 631
Creese, Ian. See Burt and Snyder, 800
Creveling, C. R. See Rotman and Daly, 887
Cunnington, Peter. See Carter, O’Malley, Beeson,
Kelvin, Vere-Hodge, Alderfer and Ts’o, 440
Cuthbert, A. W. Importance of Guanidinium Groups
for Blocking Sodium Channels in Epithelia,
945
Czernik, Andrew J. See Petrack, 203
I)
Daly, J. W. See Rotman and Creveling, 887
Daly, J. W. See Schwabe, Miyake and Ohga, 900
Dc Clercq, E., Edy, V. G., Torrence, P. F., Waters,
1108 AUTHOR INDEX
Gentleman, Susan, Abrahams, Sanders L. and
Mansour, Tag E. Adenosine Cyclic 3’ ,5’-
J. A. and Witkop, B. Antiviral Activity of
Poly(7-deazainosinic acid)-Derived Com-
plexes in Vitro and in Vivo, 1045
DeLuca, Hector F. See Stern, Mavreas, Trummel
and Schnoes, 879
Dewey, William L. See Johnson and Harris, 345
Diamond, Jack and Blisard, Karen S. Effects of
Stimulant and Relaxant Drugs on Tension
and Cyclic Nucleotide Levels in Canine Fern-
oral Artery, 688
DiAugustine, Richard P. Formation in Vitro and in
Vivo of the Isonicotinic Acid Hydrazide Ana-
logue of Nicotinamide Adenine Dinucleotide
by Lung Nicotinamide Adenine Dinucleotide
Glycohydrolase, 291
Duceman, Barry W. See Smith, Liu, Leonard and
Vesel!, 820
Duerr, A. C. See Trifaro and Pinto, 536
Dunant, Yves. See Zubler-Faivre, 1007
Dybing, E., Nelson, S. D., Mitchell, J. R., Sasame,
H. A. and Gillette, J. R. Oxidation of a-Meth-
yldopa and Other Catechols by Cytochrome P-
450-Generated Superoxide Anion: Possible
Mechanism of Methyldopa Hepatitis, 911
E
Ebstein, Richard P. SeePark, Kashimoto and Gold-
stein, 73
Edy, V. G. See De C!ercq, Torrence, Waters and
Witkop, 1045
Eikelboom, T. D. See Rodrigues de Miranda and
van Os, 454
E mler, Carol. See Butcher, Rudich and Nemerouski,
862
F
Fain, John N. See Yamamura and Rodbel!, 693
Feldmann, Richard J. See Wee, Tanis and Chignel!,
832
Felton, James S., Nebert, Daniel W. and Thorgeirs-
son, Snorri S. Genetic Differences in 2-Ace-tylaminofluorene Mutagenicity in vitro Asso-
ciated with Mouse Hepatic Aryl Hydrocarbon
Hydroxylase Activity Induced by Polycyclic
Aromatic Compounds, 225
Fertel, Richard and Weiss, Benjamin. Properties
and Drug Responsiveness of Cyclic Nucleo-
tide Phosphodiesterases of Rat Lung, 678
Forn, Javier. SeeKrueger, Walters, Roth and Green-
gard, 639
Freedman, Daniel X. See Love!!, 620
Frit, Ivo. See Cort, Car!sson, Gi!lessen, Bystrickj,
�kopkova, Gut, Studer, Mulder and Bldha,
313
G
Monophosphate in the Liver Fluke, Fasciola
hepatica. II. Activation of Protein Kinase by
5-Hydroxytryptamine, 59
Georgia, Brian. See Weiland, Wee, Chignell and
Taylor, 1091
Gillessen, Dieter. See Cort, Fri#{235}, Carlsson, Bys-
tricks, �kopkova, Gut, Studer, Mulder and
B!#{225}ha, 313
Gillette, J. R. See Dybing, Nelson, Mitchell and
Sasame, 911
Gilman, Alfred G. See Maguire and Van Arsdale,
335
Gilman, Alfred G. See Insel, Maguire, Bourne, Cof-
fino and Melmon, 1062
Goldman, I. David. See White, 711
Goldstein, Menek. See Park, Kashimoto, and Eb-
stein, 73
Green, Jack Peter. See Weinstein, Chou, Johnson
and Kang, 738
Greene, Lloyd, A. See Carpenter, Sham and Vogel,
999
Greengard, Paul. See Krueger, Forn, Walters and
Roth, 639
Grindey, Gerald B. See Lowe, 177
Groppi, Vincent E., Jr. See Browning and Bros-
trom, 32
Guidotti, A. See Kurosawa and Costa, 420
Gupta, Surendra K., Moran, John F. and Triggle,
David J. Mechanism of Action of Benzilylcho-
line Mustard at the Muscarinic Receptor,
1019Gut, Vladimir. See Cort, Fri#{235},Carlsson, Gillessen,
Bystrick�, �kopkova, Studer, Mulder and
Bl#{225}ha,313
H
Hahn, Fred E. See Krey and Olenick, 185
Harden, T. Kendall, Wolfe, Barry B. and Molinoff,
Perry B. Binding of lodinated Beta Adrener-gic Antagonists to Proteins Derived from Rat
Heart, 1
Harris, Jane E. Beta Adrenergic Receptor-Mediated
Adenosine Cyclic 3’ ,5’-Monophosphate Accu-
mulation in the Rat Corpus Striatum, 546
Harris, Louis S. See Johnson and Dewey, 345
Harris, Ward E. and Stahl, William L. Effects of
Cations and Propranolol on a Fluorescent
Phospholipid Incorporated into Brain Synap-
tosome Membranes, 115
Heliman, Bo, Idahi, Lars-Ake, Lernmark, Ake,
T#{228}ljedal, Inge-Bert and Thomas, Emrys W.
The Pancreatic f3-Cell Recognition of Insulin
Secretagogues. XII. Insulin Release in Re-
sponse to Halogenated Hexosarnines, 208
Helser, T. L. See Arya, Carter and Ts’o, 844
Hilbers, C. W. See Rodrigues de Miranda, 279
Hill, Donald L. See Bennett, Allan, Thomas and
Carpenter, 242
Hinman, Norman D. and Cann, John R. Reversible
AUTHOR INDEX 1109
Binding of Chlorpromazine to Brain Tubulin,
769
Holohan, P. D., Pessah, N. I., Warkentin, D. and
Ross, C. R. The Purification of an Organic
Cation-Specific Binding Protein from Dog
Kidney, 494Horoszewicz, Julius S. See Ts’o, Alderfer, Marsha!!,
O’Ma!!ey and Carter, 299
Horwitz, Susan B. See Liao and Kupchan, 167
Hsia, J. C. See Boggs and Yoong, 127
Hsia, J. C. SeeBoggs, Roth, Yoong and Wong, 136
Hucho, F. See Layer and Kiefer, 958
Idahl, Lars-Ake. See Hel!man, Lernmark, Td!jedal
and Thomas, 208
Insel, Paul A., Maguire, Michael E., Gilman,
Alfred G., Bourne, Henry R., Coffino, Philip
and Melmon, Kenneth L. Beta Adrenergic
Receptors and Adenylate Cyclase: Products of
Separate Genes, 1062Iversen, L. L., Rogawski, M. A. and Miller, R. J.
Comparison of the Effects of Neuroleptic
Drugs on Pre- and Postsynaptic Dopami-
nergic Mechanisms in the Rat Striatum, 251
Iwasaki, Kuzuhide. See Sugiura and Kato, 322
J
Johnson, Carl L. See Weinstein, Chou, Kang and
Green, 738
Johnson, Kenneth M., Dewey, William L. and Har-
ris, Louis S. Some Structural Requirements
for Inhibition of High-Affinity Synaptosomal
Serotonin Uptake by Cannabinoids, 345
K
Kamataki, Tetsuya, Belcher, Daniel H. and Neal,
Robert, A. Studies of the Metabolism of Di-
ethyl p-Nitrophenyl Phosphorothionate (Par-
athion) and Benzphetamine Using an Appar-
ently Homogeneous Preparation of Rat Liver
Cytochrome P-450: Effect of Cytochrome P-
450 Antibody Preparation, 921
Kamataki, Tetsuya and Neal, Robert A. Metabolism
of Diethyl p-Nitrophenyl Phosphorothionate
(Parathion) by a Reconstituted Mixed-Func-
tion Oxidase Enzyme System: Studies of the
Covalent Binding of the Sulfur Atom, 933
Kang, Sungzong. See Weinstein, Chou, Johnson and
Green, 738
Kashimoto, Takeshi. See Park, Ebstein and Gold-
stein, 73
Kato, G. and Changeux, i-P. Studies on the effect of
Histrionicotoxin on the Monocellular Electro-
plax from Electrophorus e!ectricus and on the
Binding of [3H]Acetylcholine to Membrane
Fragments from Torpedo marmorata, 92
Kato, Ryuichi. See Sugiura and Iwasaki, 322
Kawalek, Joseph. See Thomas, Lu, Ryan, West and
Levin, 746
Kelvin, Alan. See Carter, O’Ma!!ey, Beeson, Cun-
nington, Vere-Hodge, Alderfer and Ts’o, 440
Kiefer, H. R. See Layer and Hucho, 958
Kirk, Kenneth L. See Klein, Weller, Oka, Parfitt
and Owens, 720
Klein, David C., Kirk, Kenneth L., Weller, Joan L.,
Oka, Takami, Parfitt, Andrew and Owens,
Ida S. 2-Fluoro-L-histidine, an Inhibitor of
Enzyme Induction, 720
Kon, Hideo. See Rispin and Nebert, 476
Korinek, Josef. See Moses, Spe!sberg and Chytil,
731
Krey, Anne K., Olenick, John G. and Hahn, Fred E.
Interactions of the Antibiotic Distamycin A
with Homopolymeric Single-Stranded Poly-
deoxyribonucleotides and with 1X 174 Deoxy-
ribonucleic Acid, 185
Krueger, Bruce K., Forn, Javier, Walters, Judith
R., Roth, Robert H. and Greengard, Paul.
Stimulation by Dopamine ofAdenosine Cyclic
3’ ,5’-Monophosphate Formation in Rat Cau-
date Nucleus: Effect of Lesions of the Nigro-
neostriatal Pathway, 639
Ku, David. See Akera, Tobin and Brody, 101
Kuhar, Michael i. See Murrin, 1082
Kupchan, S. Morris. See Liao and Horwitz, 167
Kurosawa, A., Guidotti, A. and Costa, E. Induction
ofTyrosine 3-Monooxygenase Elicited by Car-
bamylcholine in Intact and Denervated Adre-
nal Medulla: Role of Protein Kinase Activa-
tion and Translocation, 420
L
Layer, P., Kiefer, H. R. and Hucho, F. Selective
Labeling of Anionic Binding Sites of the Ace-
tylcholinesterase from Torpedo californica
with a Photoaffinity Label, 958
Lefkowitz, Robert J. See Mukherjee, Caron and
Mullikin, 16
Lefkowitz, Robert J. See Mickey, Tate and Mulli-
kin, 409
Lefkowitz, Robert J. See Limbird, 559
Leonard, Thomas B. See Smith , Liu , Duceman and
Vese!l, 820
Lernmark, Ake. See Hellman, Idahl, Tdljeda! and
Thomas, 208
Levin, Robert M. and Weiss, Benjamin. Mechanism
by Which Psychotropic Drugs Inhibit Adeno-
sine Cyclic 3’,S’-Monophosphate Phosphodi-
esterase of Brain, 581
Levin, Wayne. See Thomas, Lu, Ryan, West and
Kawalek, 746
Levy, Judith. See Ts’o, A!derfer, Marshal!,
O’Ma!!ey, Horoszewicz and Carter, 299
Liao, Lon-Lon, Kupchan, S. Morris and Horwitz,
Susan B. Mode of Action of the Antitumor
1110 AUTHOR INDEX
Murrin, L. Charles and Roth, Robert H. Dopami-
Compound Bruceantin, an Inhibitor of Pro-
tein Synthesis, 167
Lien, E. J., Rodrigues de Miranda, J. F. and Ari#{235}ns,
E. J. Quantitative Structure-Activity Corre-
lation of Optical Isomers: a Molecular Basis
for Pfeiffer’s Rule, 598
Limbird, Lee E. and Lefkowitz, Robert J. Adenyl-
ate Cyclase-Coupled Beta Adrenergic Recep-
tors: Effect of Membrane Lipid-Perturbing
Agents on Receptor Binding and Enzyme
Stimulation by Catecholamines, 559
Liu, Dai Kee. See Smith, Leonard, Duceman and
Vesel!, 820
Lohmann, W. See Sapper, 605
Lovell, Richard A. and Freedman, Daniel X. Stere-
ospecific Receptor Sites for d-Lysergic Acid
Diethylamide in Rat Brain: Effects of Neuro-
transmitters, Amine Antagonists, and Other
Psychotropic Drugs, 620
Lowe, Jeffrey K. and Grindey, Gerald B. Inhibition
of Growth Rate and Deoxynucleoside Triphos-
phate Concentrations in Cultured Leukemia
L1210 Cells, 177
Lu, Anthony Y. H. See Thomas, Ryan, West, Kawa-
lek and Levin, 746
Lucek, Rudolph W. and Coutinho, Claude B. The
Role of Substituents in the HydrophobicBinding of the 1,4-Benzodiazepines by Hu-
man Plasma Proteins, 612
M
Maglothin, James A., Chen, Wen-Sherng and Wil-
son, Irwin B. Free Energy Relationships in
the Inhibition of Acetylcholinesterase by Di-
ethyl Phosphates, 658
Maguire, Michael E., Van Arsdale, Pamela M. and
Gilman, Alfred G. An Agonist-Specific Effect
of Guanine Nucleotides on Binding to theBeta Adrenergic Receptor, 335
Maguire, Michael E. See Inse!, Gilman, Bourne,
Coffino and Melmon , 1062
Makman, Maynard H. See Morris, 362
Manen, Carol-Ann. See Costa, Costa, Sipes and
Russell, 871
Mansour, Tag E. See Abrahams and Northup, 49
Mansour, Tag E. See Gentleman and Abrahams, 59
Marshall, Garland R. See Turk and Needleman, 217
Marshall, Lewis W. See Ts’o, Alderfer, Levy,
O’Malley, Horoszewicz and Carter, 299
Martin, T.J. SeeBoyd, 195
Matthews, E. K. and Nordmann, J. J. The Synaptic
Vesicle: Calcium Ion Binding to the VesicleMembrane and Its Modification by Drug Ac-
tion, 778
Mavreas, Thalia. See Stern, Trumme!, Schnoes and
DeLuca, 879
McCaffrey, Timothy B. See Thurman and Mc-
Kenna, 156
McKenna, William R. See Thurman and McCaffrey,
156
McPhail, Andrew T., Abou-Donia, Mohamed B. and
Rosen, Gerald M. X-ray Crystal Structure
and Conformation of a Spin-labeled Acetyl-
choline, DL-4-[N,N-Dimethyl-N-(ethan-2’-Ol-
acetate)amino] - 2,2,6,6 - tetramethylpiperi-dine-1-oxyliodide, 590
Melmon, Kenneth L. , Weinstein, Yacob, Bourne,
Henry R., Poon, Tak, Shearer, Gene and
Castagnoli, Neal, Jr. The Pharmacological
Effects of Conjugates of Pharmacologically
Active Amines to Complex or Simple Car-
riers: a New Class of Drug, 701
Melmon, Kenneth L. See Insel, Maguire, Gilman,
Bourne, and Coffino, 1062
Mickey, John V., Tate, Robert, Mullikin, Debra
and Lefkowitz, Robert J. Regulation of Aden-
ylate Cyclase-Coupled Beta Adrenergic Re-
ceptor Binding Sites by Beta Adrenergic Cat-
echolamines in Vitro, 409
Miller, R. J. See Iversen and Rogawski, 251
Minkel, Daniel T., Chan-Stier, Christine and Peter-
ing, David H. Reactions of 3-Ethoxy-2-oxobu-
tyraldehyde Bis(N4-dimethylthiosemicarba-
zonato)-Zinc(II) with Tumor Cells and Mito-chondria, 1036
Mitchell, J. R. See Dybing, Nelson, Sasame and
Gillette, 911
Mittag, T. W. See Collier and Barker, 340
Miyake, M. See Schwabe, Ohga and Daly, 900
Molinoff, Perry B. See Harden and Wolfe, 1
Moran, John F. See Gupta and Triggle, 1019
Morgenroth, Victor H., Boadle-Biber, Margaret C.
and Roth, Robert H. Dopaminergic Neurons:
Activation of Tyrosine Hydroxylase by a Cal-
cium Chelator, 41
Morgenroth, Victor H., III. See Murrin and Roth,
1070
Morris, Stephen A. and Makman, Maynard H. Cell
Density and Receptor-Adenylate Cyclase Re-
lationships in the C-6 Astrocytorna Cell, 362
Moses, Harold L. , Spelsberg, Thomas C., Korinek,
Josef and Chytil, Frank. Porphyria-Inducing
Drugs: Comparative Effects on Nuclear Ribo-nucleic Acid Polymerases in Rat Liver, 731
Mukherjee, Chhabirani, Caron, Marc G., Mullikin,
Debra, and Leflowitz, Robert J. Structure-
Activity Relationships of Adenylate Cyclase-
Coupled Beta Adrenergic Receptors: Determi-nation by Direct Binding Studies, 16
Mulder, Jan L. See Cort, Fri#{235},Carlsson, Gillessen,
Bystricky, �kopkova, Gut and Bldha, 313Mullikin, Debra. See Mukherjee, Caron and Le/kow-
itz, 16
Mullikin, Debra. See Mickey, Tate and Lefkowitz,
409
AUTHOR INDEX 1111
nergic Neurons: Effects of Electrical Stimula-
tion on Dopamine Biosynthesis, 463
Murrin, L. Charles and Kuhar, Michael J. Activa-tion of High-Affinity Choline Uptake in Vitro
by Depolarizing Agents, 1082Murrin, L. Charles, Morgenroth, Victor H., III and
Roth, Robert H. Dopaminergic Neurons: Ef-fects of Electrical Stimulation on Tyrosine
Hydroxylase, 1070
N
Nathanson, i. A. and Bloom, F. E. Heavy Metalsand Adenosine Cyclic 3’,5’-MonophosphateMetabolism: Possible Relevance to Heavy
Metal Toxicity, 390Neal, M. J., Butler, K. W., Polnasek, C. F. and
Smith, Ian C. P. The Influence of Anesthetics
and Cholesterol on the Degree of MolecularOrganization and Mobility of Ox Brain White
Matter. Lipids in Multibilayer Membranes: a
Spin Probe Study Using Spectral Simulation
by the Stochastic Method, 144Neal, Robert A. See Kamataki and Belcher, 921
Neal, Robert A. See Kamataki, 933
Nebert, Daniel W. See Felton and Thorgeirsson, 225
Nebert, Daniel W. See Rispin and Kon, 476
Needleman, Philip. See Turk and Marshall, 217
Neff, N. H. See Yang, H.-Y. T. , 69
Neff, N. H. See Yang, 433
Nelson, S. D. See Dybing, Mitchell, Sasame and
Gillette, 911
Nelson, Wendel L. See Wirth and Bettis, 759
Nemerovski, Mark. See Butcher, Rudich and Emler,
862
Nordmann, i. J. See Matthews, 778
Northup, John K. SeeAbrahams and Mansour, 49
Novak, R. F. and Swift, T. J. Nuclear MagneticResonance Studies of Barbiturate-Phospho-lipid Interactions, 263
0
Ohga, Y. See Schwabe, Miyake and Daly, 900
Oka, Takami. See Klein, Kirk, Weller, Parfitt and
Owens, 720
Olenick, John G. See Krey and Hahn, 185
O’Malley, Judith. See Ts’o, Alderfer, Levy, Horo-
szewicz and Carter, 299O’Malley, Judith. See Carter, Beeson, Cunnington,
Kelvin, Vere-Hodge, Alderfer and Ts’o, 440
Ontjes, David A. See Ways and Zimmerman, 789
Onur, R. SeeAlbuquerque, Brooks, and Warnick, 82
Otten, U. and Thoenen, H. Selective Induction ofTyrosine Hydroxylase and Dopamine /3-Hy-
droxylase in Sympathetic Ganglia in OrganCulture: Role of Glucocorticoids as Modula-
tors, 353
Owens, Ida S. See Klein, Kirk, Weller, Oka and
Parfitt, 720
P
Parfitt, Andrew. See Klein, Kirk, Weller, Oka and
Owens, 720
Park, Dong H., Kashimoto, Takeshi, Ebstein,Richard P. and Goldstein, Menek. Purifica-
tion and Immunochemical Characterization
of Dopamine /3-Hydroxylase from Human
Pheochromocytoma, 73
Pasternak, Gavril W., Simantov, Rabi and Snyder,Solomon H. Characterization of an Endoge-
nous Morphine-like Factor (Enkephalin) in
Mammalian Brain, 504Pessah, N. I. SeeHolohan, Warkentin andRoss, 494
Petering, David H. See Minkel and Chan-Stier, 1036Petrack, Barbara and Czernik, Andrew J. Inhibi-
tion of Isoproterenol Activation of Adenylate
Cyclase by Metoprolol, Oxprenolol, and the
para Isomer of Oxprenolol, 203
Philpot, R. M. and Arin#{231}, Emel. Separation and
Purification of Two Forms of Hepatic Cyto-
chrome P-450 from Untreated Rabbits, 483
Pinto, J. E. B. See Trifaro and Duerr, 536
Polnasek, C. F. See Neal, Butler and Smith, 144
Poon, Tak. See Melmon, Weinstein, Bourne,
Shearer and Castagnoli, 701
R
Rang, H. P. See Colquhoun, 519
Rispin, Amy S., Kon, Hideo and Nebert, Daniel W.Electron Spin Resonance Study of ‘7O-En-
riched Oxybenzo[a]pyrene Radical, 476
Rodbell, Martin. See Yamamura and Fain, 693Rodriques de Miranda, J. F. and Hilbers, C. W. A
Nuclear Magnetic Resonance Study of the Ki-
netics of the Binding of the Renal Contrast
Medium Acetrizoate to Albumin, 279
Rodrigues de Miranda, J. F., Eikelboom, T. D. and
van Os, G. A. J. The Extent of HydrophobicBinding Area Studied by Fatty Acid Binding
to Albumin, 454
Rodrigues de Miranda, J. F. See Lien and Ari#{235}ns,
598
Rogawski, M. A. See Iversen and Miller, 251
Rosen, Gerald M. See McPhail and Abou-Donia, 590Rosenberry, Terrone L. See Bartels-Bernal and
Chang, 813
Ross, C. R. SeeHolohan, Pessah and Warkentin, 494Roth, Robert H. See Morgenroth and Boadle-Biber,
41
Roth, Robert H. See Murrin, 463Roth, Robert H. See Krueger, Forn, Walters and
Greengard, 639
Roth, Robert H. See Murrin and Morgenroth , 1070
Roth, S. H. See Boggs, Yoong, Wong and Hsia, 136Rotman, A., Daly, J. W. and Creveling, C. R. Oxy-
gen-Dependent Reaction of 6-Hydroxydopa-mine, 5,6-Dihydroxytryptamine, and Related
Compounds with Proteins in Vitro: a Model
1 112 AUTHOR INDEX
for Cytotoxicity, 887
Ruddon, Raymond W. See Bittner, 966
Rudich, Lynn. See Butcher, Emler and Nemerovski,
862
Russell, Diane Haddock. See Costa, Costa, Manen
and Sipes, 871
Ryan, Dene. See Thomas, Lu, West, Kawalek and
Levin , 746
S
Same, Susan E. and Strobel, Henry W. Drug Me-tabolism in Liver Tumors. Resolution of Com-
ponents and Reconstitution of Activity, 649
Sapper, H. and Lohmann, W. Self-association and
Binding Sites of Some Psychotomimetic
Tryptamine Derivatives and Related Corn-
pounds: Nuclear Magnetic Resonance Investi-
gations, 605
Sasame, H. A. See Dybing, Nelson, Mitchell and
Gillette, 911
Schnoes, Heinrich K. SeeStern, Mavreas, Trummel
and DeLuca, 879
Schwabe, U., Miyake, M., Ohga, Y. and Daly, J. W.
4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyr-
rolidone (ZK 62711): a Potent Inhibitor of
Adenosine Cyclic 3’ ,5’-Monophosphate Phos-
phodiesterases in Homogenates and Tissue
Slices from Rat Brain, 900
Sham, William. See Carpenter, Greene and Vogel,
999
Shearer, Gene. See Melmon, Weinstein, Bourne,
Poon and Castagnoli, 701
Sheppard, Herbert, Burghardt, Charles R. and Tei-
tel, Sidney. The Dopamine-Sensitive Adenyl-
ate Cyclase ofthe Rat Caudate Nucleus. II. A
Comparison with the Isoproterenol-Sensitive
(Beta ) Adenylate Cyclase of the Rat Erythro-
cyte for Inhibition or Stimulation by Tetrahy-
droisoquinolines, 854
Simantov, Rabi. See Pasternak and Snyder, 504
Simantov, Rabi, Snowman, Adele M. and Snyder,Solomon H. Temperature and Ionic Influ-
ences on Opiate Receptor Binding, 977
Simantov, Rabi and Snyder, Solomon H. Morphine-
Like Peptides, Leucine Enkephalin and Me-
thionine Enkephalin: Interactions with the
Opiate Receptor, 987
Sinha, Birandra K. See Wee, Taylor and Chignell,
667
Sipes, I. Glenn. See Costa, Costa, Manen and Rus-
sell, 871
�kopkova, Jana. See Cort, Fri#{235},Car!sson, Gillessen,
Bystricky, Gut, Studer, Mulder and Bl#{225}ha,
313
Smith, Ian C. P. See Neal, Butler and Polnasek , 144
Smith, Steven J., Liu, l)ai Kee, Leonard, Thomas
B., Duceman, Barry W. and Vesell, Elliot S.
Phenobarbital-Induced Increases in Methyla-
tion in Ribosomal Precursor Ribonucleic
Acid, 820
Snowman, Adele M. See Simantov and Snyder, 977
Snyder, Solomon H. See Bennett, 373
Snyder, Solomon H. See Pasternak and Simantov,
504
Snyder, Solomon H. See Bylund, 568
Snyder, Solomon H. See Burt and Creese, 800
Snyder, Solomon H. See Simantov and Snowman,
977
Snyder, Solomon H. See Burt and Creese, 631
Snyder, Solomon H. See Simantov, 987
Spelsberg, Thomas C. See Moses, Korinek and Chy-
til, 731
Stahl, William L. See Harris, 115
Stern, Paula H., Mavreas, Thalia, Trummel, Clar-
ence L. , Schnoes, Heinrich K. and DeLuca,
Hector F. Bone-Resorbing Activity of Ana-
logues of 25-Hydroxycholecalciferol and 1,25-
Dihydroxycholecalciferol: Effects of Side
Chain Modification and Stereoisomerization
on Responses of Fetal Rat Bones in Vitro, 879
Strobel, Henry W. See Same, 649
Studer, Rolf 0. See Cort, Fri#{235},Carlsson, Gillessen,
Bystrick�, �kopkova, Gut, Mulder and Bl#{225}ha,
313
Sudlow, G., Birkett, 1). J. and Wade, D. N. Further
Characterization of Specific Drug Binding
Sites on Human Serum Albumin, 1052
Sugiura, Masahiko, Iwasaki, Kuzuhide and Kato,Ryuichi Reduction of Tertiary Amine N-Ox-
ides by Liver Microsomal Cytochrome P-450,
322
Swift, T. J. See Novak, 263
T
T#{225}ljedal, Inge-Bert. See Hellman, ldahl, Lernmark
and Thomas, 208
Tanis, Robert J. See Wee, Feldmann and Chignell,
832
Tate, Robert. See Mickey, Mullikin and Le/kowitz,
409
Taylor, Palmer W. See Sinha, Wee and Chignell,
667
Taylor, Palmer. See Weiland, Georgia, Wee and
Chigne!!, 1091
Teitel, Sidney. See Sheppard and Burghardt, 854
Thoenen, H. See Otten, 353
Thomas, Emrys W. See He!lman, Idahl, Lernmark
and Tdljedal, 208
Thomas, H. Jeanette. See Bennett, Allan, Hill and
Carpenter, 242
Thomas, Paul E., Lu, Anthony Y. H., Ryan, Dene,
West, Susan B., Kawalek, Joseph and Levin,
Wayne. Immunochemical Evidence for Six
Forms of Rat Liver Cytochrome P450 Ob-
tamed Using Antibodies against Purified Rat
Liver Cytochromes P450 and P448, 746
AUTHOR INDEX 1113
Thorgeirsson, Snorri S. See Felton and Nebert, 225
Thurman, Ronald G., McKenna, William R. and
McCaffrey, Timothy B. Pathways Responsi-
ble for the Adaptive Increase in Ethanol Uti-
lization Following Chronic Treatment with
Ethanol: Inhibitor Studies with the Hemoglo-
bin-Free Perfused Rat Liver, 156
Tobin, Thomas. See Akera, Ku and Brody, 101
Torrence, P. F. See De C!ercq, Edy, Waters and
Witkop, 1045
Trifar#{243}, J. M., Duerr, A. C. and Pinto, J. E. B.
Membranes of the Adrenal Medulla: a Corn-
parison between the Membranes of the Golgi
Apparatus and Chromaffin Granules, 536
Triggle, David J. See Gupta and Moran, 1019
Tritton, Thomas R. See Bina-Stein, 191
Trummel, Clarence L. See Stern, Mavreas, Schnoes
and DeLuca, 879
Ts’o, Paul 0. P. See Arya, Carter and Alderfer, 234
Ts’o, Paul 0. P., Alderfer, James L., Levy, Judith,
Marshall, Lewis W., O’Malley, Judith, Horo-
szewicz, Julius S. and Carter, William A. An
Integrated and Comparative Study ofthe An-
tiviral Effects and Other Biological Proper-
ties of the Polyinosinic Acid-Polycytidylic
Acid and Its Mismatched Analogues, 299
Ts’o, Paul 0. P. See Carter, O’Mal!ey, Beeson, Con-
nington, Kelvin, Vere-Hodge and Ts’o, 440
Ts’o, P. 0. P. See Arya, Helser and Carter, 844
Turk, John, Needleman, Philip and Marshall, Gar-
land R. Analogues of Angiotensin II with Re-
stricted Conformational Freedom Including a
New Antagonist, 217
V
Van Arsdale, Pamela M. See Maguire and Gilman,
335van Os, G. A. J. See Rodrigues de Miranda and
Eikelboom , 454
Vere-Hodge, Anthony. See Carter, O’Malley, Bee-
son, Cunnington, Kelvin, Alderfer and Ts’o,
440
Vesell, Elliot S. See Smith, Liu, Leonard and Duce-
man, 820
Vogel, Zvi. See Carpenter, Greene and Sham , 999
W
Wade, D. N. See Sudlow and Birkett, 1052
Walters, Judith R. See Krueger, Forn, Roth and
Greengard, 639
Warkentin, D. See Holohan , Pessah and Ross, 494
Warnick, J. E. See Albuquerque, Brooks and Onur,
82
Waters, J. A. See De Clercq, Edy, Torrence and
Witkop, 1045
Ways, D. Kirk, Zimmerman, Carol F. and Ontjes,
David A. Inhibition of Adrenocorticotropin
Effects on Adrenal Cell Membranes by Syn-
thetic Adrenocorticotropin Analogues: Corre-
lation of Binding and Adenylate Cyclase Acti-
vation, 789
Wee, Victorio T., Sinha, Birandra K., Taylor, Pal-
mer W. and Chignell, Cohn F. Interaction of
Spin-Labeled Bisquarternary Ammonium Li-
gands with Acetylcholinesterase, 667
Wee, Victorio T., Feldmann, Richard J., Tanis,
Robert J. and Chignell, Cohn F. A Compara-
tive Study of Mammalian Erythrocyte Car-
bonic Anhydrases Employing Spin-Labeled
Analogues of Inhibitory Sulfonamides, 832
Wee, Victorio T. See Weiland, Georgia, Chignel!
and Taylor, 1091
Weiland, Gregory, Georgia, Brian, Wee, Victorio
T., Chignell, Cohn F. and Taylor, Palmer.
Ligand Interactions with Cholinergic Recep-
tor-Enriched Membranes from Torpedo: In-
fluence of Agonist Exposure on Receptor
Properties, 1091
Weinstein, Harel, Chou, David, Johnson, Carl L.,
Kang, Sungzong and Green, Jack Peter. Tau-
tomerism and the Receptor Action of Hista-
mine: a Mechanistic Model, 738
�Veinstein, Yacob. See Melmon, Bourne, Poon,
Shearer and Castagnoli, 701
%Veiss, Benjamin, See Levin, 581
Weiss, Benjamin. See Fertel, 678
Weller, Joan L. See Klein, Kirk, Oka, Parfitt and
Owens, 720
West, Susan B. See Thomas, Lu, Ryan, Kawalek
and Levin , 746
White, J. Courtland and Goldman, I. l)avid. Mecha-
nism of Action of Methotrexate. IV. Free In-
tracellular Methotrexate Required to Sup-
press Dihydrofolate Reduction to Tetrahydro-
folate by Ehrlich Ascites Tumor Cells in Vi-
tro, 711
Wilson, Irwin, B. See Maglothin and Chen, 658
Wilson, William Robert. See Cain and Bagu!ey,
1027
Wirth, Peteri., Bettis, Carol J. and Nelson, %Vendel
L. Microsomal Metabolism ofFurosemide Ev-
idence for the Nature of the Reactive Inter-
mediate Involved in Covalent Binding, 759
Witkop, B. See De Clercq, Edy, Torrence and Wa-
ters, 1045
Wolfe, Barry B. See Harden and Molinoff, 1
Wong, E. See Boggs, Roth, Yoong and Hsia, 136
Y
Yamamura, Hirohei, Rodbell, Martin and Fain,
John N. Hydroxybenzylpindolol and Hydrox-
ybenzylpropranolol: Partial Beta Adrenergic
Agonists of Adenylate Cyclase in the Rat Adi-
pocyte, 693
Yang, H.-Y. T. and Neff, N. H. N-Acetyltransferase
of Brain: Some Properties of the Enzyme and
the Identification of f3-Carboline Inhibitor
1114 AUTHOR INDEX
(Signed) Ellsworth B. Cook, Executive Secretary
Compounds, 69
Yang, H.-Y. T. and Neff, N. H. Hydroxyindole 0-
Methyltransferase: An Immunochemical
Study of the Neuronal Regulation of the Pi-
neal Enzyme, 433
Yoda, Atsunobu. Binding of Digoxigenin to Sodium-
and Potassium-Dependent Adenosine Tn-
phosphatase, 399
Yoong, T. See Boggs and Hsia, 127
Yoong, T. See Boggs, Roth, Wong and Hsia, 136
Z
Zimmerman, Carol F. See Ways and Ontjes, 789
Zubler-Faivre, Liliane and Dunant, Yves. Sodium-and Potassium-Dependent Adenosine Tn-
phosphatase of Electric Organ: Interaction
with Ouabain in Situ, in a Membrane Frac-
tion, and in the Solubilized Form, 1007
Statement ofownership, management and circulation required by the Act of October 23, 1962, Section 4369, Title 39, UnitedStates Code; of
MOLECULAR PHARMACOLOGY
Published bimonthly by Academic Press, Inc., 111 Fifth Avenue, New York, N. Y. 10003. Number of issues published an-nually: 6. Editor: G. I. Drummond, Dept. of Chemistry, The Univ. of Calgary, Alberta, T2N, 1N4, Canada.Owned by American Society for Pharmacology and Experimental Therapeutics, 9650 Rockville Pike, Bethesda, Md. 20014.Known bondholders, mortgagees, and other security holders owning or holding 1 percent or more of total amount of bonds,mortgages or other securities: None.Paragraphs 2 and 3 include, in cases where the stockholder or security holder appears upon the books of the company astrustee or in any other fiduciary relation, the name of the person or corporation for whom such trustee is acting, also thestatements in the two paragraphs show the affiant’s full knowledge and belief as to the circumstances and conditions underwhich stockholders and security holders who do not appear upon the books of the company as trustees, hold stock andsecurities in a capacity other than that of a bona fide owner. Names and addresses of individuals who are stockholders of acorporation which itself is a stockholder or holder ofbonds, mortgages or other securities ofthe publishing corporation havebeen included in paragraphs 2 and 3 when the interests of such individuals are equivalent to 1 percent or more of the totalamount of the stock or securities of the publishing corporation.Total no. copies printed: average no. copies each issue during preceding 12 months: 2102; single issue nearest to filing date:1906. Paid circulation (a) to term subscribers by mail, carrier delivery or by other means: average no. copies each issue dur-ing preceding 12 months: 1494; single issue nearest to filing date: 1439. (b) Sales through agents, news dealers, or other-wise: average no. copies each issue during preceding 12 months: 0; single issue nearest to filing date: 0. Free distribution bymail, carrier delivery, or by other means: average no. copies each issue during preceding 12 months: 92; single issue nearestto filing date: 92. Total no. ofcopies distributed: average no. copies each issue during preceding 12 months: 1586; single issuenearest to filing date: 1531.
A�tasot� m4e , �rhonw §nhy4r�t� ,
A��tri�o�le, bovtn� �r�im �Ib�irnin �79
� �4�tivt4U�n to muta�in , 225Ae�ty1ehohns�Ler�s@ 65$, 667
binding si�e�, 1J911
binding sp�i�I1�(y ofbisqu�tern�ry Iig�n4s, 667
phoLo�ffinIt� Isb�l�nM ��Llbstr�le$, 840
A�etyIehoIiim r��epuir,qIplrn�Ining�*n�u�in bin4in�, UUU
bon�iIyl�holjne m�tsr4 b(ndin� 1019
binding � 999
�h�mse�l modifie�tion, $13from Torpedo rniirnortsti, 92
A�ty�mono�LhyI�ho1mne, �ynthti��erv�I gsnghon, 340
A�tylpyrru�hulin�, �ynLh�s� in �t ��p�rior �rvt�
e�I g�n�lion, 340�
bri4in,89inthwtion, 720
4 ‘-(9’A�r141nyl�mlno � �(ur� �etivity rel�tion�hip, 1027
M�ntrlti nueIeot(th� r�nsIoei�e, �iLh�nol meI�boli�min liver, 158
A4t3nQ�ine, 1400
Ad�nosine Kin�se , �,�nr�bi � ��ibstr�tt�, 242
Ad�no�in�� 3’ 5�monophoMph�te,�ff�I!L on tyrosl,m hydro�yh�bt�, 1070
Ath�no�itm 3’,S�monopho�ph�te,�nd dop�mi�w, 839
nUd IipoIy�, 898bindsn� to t’i� Ii�ng �yeIie �nwIeoti4e phospho4ius�
(�r�e, 878
III i�nine femor�l �rt�ry 8MMin Itiuktwy(�is, 701
In p�rot�t1 �1i�n4, 882
In nfl eorpt4s �trm�Rirn, 546m��bofl�m, 390
Atisnosirse 8’ S’�mcmophosphi�te phosphodie�teri�se
§�l1v1flor in bovine bri*)n, 581
hsi��vy met�I inhibition, 390
1nh�bslors, 900
Ad�innsin@ (rlpho�ph�t�t� N�*’ -� K”,
binding of 4igoM�nIn, 399
eLhi*not rn�U*boIi�rn in Iiv�r, 158oI4O�in compl�Me� in rst br�*in �nd 4o�t h�rt, 101
oui�b�*In in1�r�rtion, 1007
Adtinylsl@ eye1s�e
Bt� idrstwrgi� re�plor 1, 18, 4014, 559, 1062
III �trot�,v(onH* eell� 382
to i�ttid�te ntwtt�u�, 839inhibition b,v h�’iivy me& 890
in 1�ukoeyLe� 7111
ILl preneopI�*�tc i’�t hver 195
in r�fl �*4ipoe,v1e; 693in rat eorpi� �tr1�ILIm; 546
�sJn�lt1v1(y to dop�*mine, $f14
Adrenoeortieotrophic hormone,�wtivetion of etIenyle�e ey�Ie�e in ret e�1rennI
membrene, 789
tregmenLe es inhibstor� 789AffinIty ree�ent� for eeetykholine receptor $13
Albumin fetty eeitl hintling 454
M�ohnI dehydrogenece , ethenol meteboliem inliver 158
Mlylisopropyleeetemide 731
A/p/rn�Arebino�yle4enine 242
� 242Mp!w, heui�enomer� of nocleoLideb seperelion, 242
A/pbo�Bun�eroLo�in, bin4in� �o welyk’holine re��eptor 519 999
A/pho�Me�hyl4ope o�ideLion, 911
Mprenolol 18
hy4roMyphenyl dtirivetivee 1
Amiloride lnhihiLor of eodium Lren�porL 945
2�Amino�8,7�4ihy4r*y� 1 2,34�ietrehy4roneph�he�lens, 251
Aminophylline, $71
Amitryptyline, 581
Amphetemine, 581
fluke molility 414
Amphotericin B, 551)
Amyloherbilone, 77$
Amyle$e, end pertflid glend $62Anesthetiv eetion, 127 138, 144
Ane�Lhetic$, orc1erin� efleci t�n lipid vti���le�, 144
Angicsten$in II, 313
enelogue$ enti �on)�rmetitin 217
Mflibodiee Cyt&whrome P�4511, 746
Antimyein A� uthenol metehulism to hver, 15(1
Apomorphine 251
Arcwlor�l254, en�yme snc4uet(on $71
Ar�l hyiiroeerbon hydro�yle�e sndLwtlon 720 988
As�orhie �wid, 911
Mreeylo�i4e ethenol ,imieboliern lo ltvor, 156
A(rup�ne, $82
Aorintrwerbo�ylic ecid n#inepocs0� trniyme )nhibs-
(or in preneopleeic ret l$ver, 1111
Betreeho(ti�in, ret diephre�jm mo�ele $2
MOLECULAR PHARMACOLOGY, 12, 1115-1119
Copynght � 19711 b� #4�ssedeni�e Pres� ItwMI right� of repro4or(ion in sn� form reserved
A
SUBJECT INDEX
in �t �perior
Ills
LI
1116 SUBJECT INDEX
Benperidol, 581
Benzamil, inhibitor of sodium transport, 945
Benzanthracene, aryl hydrocarbon hydroxylase in-
duction, 966
Benzilylcholine mustard , acetylcholine receptor,
1019
Benzolalpyrene hydroxylase, 225
Benzo[a Ipyrene , liver microsome metabolism , 476
1,4-benzodiazepine, binding to plasma proteins, 612
Benzphetamine, Cytochrome P-450, 921
hydroxylation, 649
Benztropine, 251
Benzyl alcohol, 728
Beta-Adrenergic agonists, to frog erythrocyte, 16
Beta-Adrenergic antagonists,
to dog liver and heart, 203
to frog erythrocyte, 16
to rat heart, 1
Beta-Adrenergic receptor,
and adenylate cyclase, 559, 1062
and guanine nucleotides, 335
in rat and monkey brain, 568
in rat corpus striatum, 546
Beta-Carboline derivatives, brain and pineal N-ace-
tyltransferase, 69
Beta-Cell recognition, of halogenated hexosamines,
208
Bis(thiosemicarbazonato -zinc complexes , interac-
tion with mitochondria, 1036
Bovine serum albumin, acetrizoate binding, 279
N-Bromoacetylglycosylamines, insulin release, 208
8-Bromoguanosine-3’ ,5’-monophosphate,
parotid gland, 862
Bruceantin, inhibition of protein synthesis, 167
Butyrophenone haloperidol, adenylate cyclase, 251
C
Calcium, adsorption to synaptic vesicles, 778
Carbachol, 688
Carbamylcholine,
depolarization of electroplax, 92
induction of tyrosine hydroxylase and dopamine
/3-hydroxylase, 353
induction of tyrosine 3-monooxygenase, 420
Carbonic anhydrase I and II, active site topography,
832
Catecholamine , adenylate cyclase , 195
Catecholamine receptor, adenylate cyclase complex,
362
Catecholamine tolerance, /3-adrenergic receptor, 409
Catechol synthesis, 251
Chlordiazepoxide, 581
Chlorisondamine, 353
Chlorpromazine, 546, 581
binding to brain tubulin, 769
Chlorprothixene, 581
Choline uptake, by rat brain hippocampol synapto-
somes, 1082
Chromaffin granules, enzyme markers, 536
Circular dichroism, vasopressin analogues, 313
Conformation, spin labeled acetylcholine analogue,
590
Cyclic nucleotide phosphodiesterase,
epinephrine induction in astrocytoma cells, 32
in liver fluke, 49, 59
in rat lung, 678
Cyclic nucleotides,
in astrocytoma cells, 32
in canine femoral artery, 688
Cytochrome P-448, 759
reactivity with anticytochrome P-450, 746
Cytochrome P-450, 225, 649, 759, 871
antibody, 921
antibodies, 746
as N-oxide reductase, 322
catecholamine oxidation, 911
different forms in rat liver, 746
in rat liver, 921
purification of two forms, 483
Cytochrome P-450 monooxygenase, 759
Cytosine arabinoside, 966
D
1-Deamino-[8-D-argininej-vasopressin, 313
Delta-Aminolevulinic acid synthetase, 731
Deoxynucleosides, inhibitors of L1210 cell growth,
177
Deoxynucleotide triphosphate and growth inhibi-
tion of L1210 cells, 177
Deoxyribonucleic acid polymerase, inhibited by pu-
rine ribonucleotides, 844
Desipramine, 581
Dexamethasone, induction of dopamine /3-hydroxyl-
ase and tyrosine hydroxylase, 353
Dibutyryl adenosine 3’ ,5’-monophosphate, 871
3,5-Dicarbethoxy-1,4-dihydrocollidine, 731
Diethylphospho - acetylcholinesterase, activation,
658
Digoxigenin, binding to adenosine triphosphatase
(Nat + KF), 399
Dihydroalprenolol, f3-adrenergic receptor, 409, 559,
568
Dihydrofolate, effect of methotrexate on metabolism
of, 711
Dihydromorphine, 977
1 ,25-Dihydroxycholecalciferol, bone resorbing activ-
ity, 879
Dihydroxyphenyl acetic acid, see Dopa
5,6-Dihydroxytryptamine, protein binding, 887
DL-4-[N,N-Dimethyl-N-(ethan-2’-olacetate)aminol-
2,2,6,6-tetramethylpiperidine-1-oxyl iodide,
590
Dissociation constant, iodohydroxybenzylpindolol to
rat heart protein, 1
Dissociation constants, of frog erythrocyte /3-adre-
nergic receptor, 16
Distamycin, interaction with single stranded deoxy-
ribonucleic acids, 185
Dopa, 911
SUBJECT INDEX 1117
Medazepam, 581
Dopa decarboxylase, 353, 463
Dopamine, inhibitor of tyrosine hydroxylase, 1070
Dopamine, 251, 546, 911
binding to calf brain membranes, 800
stimulation of adenylate cyclase, 639
synthesis in dopaminergic neurons, 463
Dopamine beta-hydroxylase,
immunochemical characterization, 73
induction in sympathetic ganglia, 353
E
Electrical stimulation of dopaminergic neurons,
control of dopamine synthesis, 1070Electron spin resonance,
active site of carbonic anhydrase, 832
nerve conductance, 136
of lipid vesicles, 127, 144
of oxybenzo[ajpyrene radical, 476
of spin labeled bisquaternary ammonium ligands
and their interaction with acetylcholinester-
ase, 667
Enkephalin,
in mammalian brain, 504
leucine, methionine analogues, 987
Epinene, 251
Epinephrine, 546, 789, 911
stimulatidn of adenylate cyclase, 362, 789
Epoxide hydrase, 759
1 ,2-Epoxy-3,3,3-trichloropropane, 759
Eserine, and acetylcholine receptor, 999
Ethanol metabolism, 156
Ethylenediamine, 911
Ethylene glycol bis(/3-aminoethyl ether-N,N’-tet-
raacetic acid,
and tyrosine hydroxylase from dopaminergic neu-
rons, 41
inhibitor of phosphodiesterase, 581
F
Filipin, 559
Fluorescence, of drug binding to albumin, 1052Fluorescent phospholipid, brain synaptosome mem-
brane, 115
Fluoride, adenylate cyclase stimulation, 789
2-Fluoro-L-histidine, inhibitor of enzyme induction,
720
Folic acid metabolism, 711
Furosemide, binding to microsomal proteins, 759
G
Gamma-Aminobutyric acid, uptake by synapto-
somes, 1082
Genes, for adenylate cyclase and f3-adrenergic re-
ceptor, 1062
Glucagon, and adenylate cyclase, 195Glucocorticoid, induction of tyrosine hydroxylase
and dopamine /3-hydroxylase, 353Glutathione, 911
Golgi apparatus, enzyme markers, 536
Guanidinium group, blockage of sodium transport,
945
Guanine nucleotides, /3-adrenergic agonist effector,
335
Guanosine 3’ ,5’-monophosphate, 678, 688
in rat parotid gland, 862
H
Haloperidol, 251
binding to calf brain membrane, 800
Histamine, 900
conjugated to albumin, 701
tautomeric forms, 738
Histone kinase, activation in adrenal medulla, 514
Histrionicotoxin, monocellular electroplax and ace-
tylcholine receptor, 92
Human serum albumin, drug binding, 1052
Hydrophobic binding, fatty acids to albumin, 454
N-Hydroxy-2-acetylaminofluorene, mutagenicity,
225
Hydroxybenzylpindolol,
rat adipocyte adenylate cyclase, 693
rat heart adenylate cyclase, 693
Hydroxybenzylpropranolol, rat adipocyte adenylate
cyclase, 693
25-Hydroxycholecalciferol, bond resorbing activity,
879
6-Hydroxydopamine, protein binding, 887
Hydroxyindole O-methyltransferase, neuronal reg-
ulation of pineal enzyme, 433
Insulin secretagogues, 208
Interferon induction, 299, 1045
lodinated beta -adrenergic antagonists , 1
N-Iodoacetyl-2-amino-2-deoxy-D-glucose, insulin re-
lease, 208
Iodohydroxybenzylpindolol, 1 , 335, 1062
Ions, effect on opiate receptor binding, 977
Isoniazid, 291
Isoprenaline, 251
Isoproterenol, 1062
adenylate cyclase activity, 409, 900
adenylate cyclase stimulation, 1, 203
and guanosine 3’ ,5’-monophosphate, 862
L
Lidocaine, on rat diaphragm muscle, 82
D-Lysergic acid diethylamide, 581
and fluke motility, 49, 59
binding to dopamine receptors, 631
binding to rat brain membrane, 373, 800
nuclear magnetic resonance, 605
receptor in rat brain, 620
self association, 605
M
1118 SUBJECT INDEX
Papaverine, 688
Parathion, cytochrome P-450 binding, 921, 933
Membranes, golgi apparatus and chromaffin gran-
ules, 536
Metaprolol, adenylate cyclase inhibitor, 203
Methiothepin, 620
Methotrexate, dihydrofolate reductase, 711
3-Methylcholanthrene, 731, 759, 945
3’-Methyl-4-diaminoazobenzene, effect on rat liver,
195
4-Methylpyrazole, and alcohol dehydrogenase, 156
Microelectrophoresis, of synaptic vesicles, 778
Mitochondrial respiration, inhibition, 1036
Mixed disulfide, in acetylcholine receptor, 813Molecular orbital calculation, histamine, 738
Morphine, 581
Muscarinic receptor, 1019
Muscle contraction, and cyclic nucleotide levels, 688
N
NADPH-Cytochrome P-450 reductase, purification,
649, 921
Naloxone, 977Neostigmine, acetylcholine receptor, 999
Nerve conduction, pressure effect, 136
Neuroleptics, 251
Nicotinamide adenine dinucleotide glycohydrolase,
291
Nitroglycerin, 688
Norepinephrine, 251, 900, 911
conjugated to albumin, 701
level of guanosine 3’ ,5’-monophosphate, 862
Nuclear magnetic resonance,
acetrizoate and albumin, 279barbiturates and phospholipid, 263
D-lysergic acid diethylamide, 605
0
Octopamine, uptake by synaptosomes, 1082Opiate receptor, and enkephalin distribution, 504
Opiate receptor binding,of enkephalin analogues, 977
temperature and ion effect, 977Organic cation, specific binding protein, purifica-
tion from dog kidney, 494
Ornithine decarboxylase, induction, 720, 871
Ouabain,effect of digoxigenin binding to adenosine triphos-
phatase (Na� + K�), 399
ethanol metabolism in liver, 156
interaction with adenosine triphosphatase (Na� +
Ki, 1007Oxidation, of catecholamines bound to proteins, 887
N-Oxide reductase, associated with cytochrome P-
450, 322
Oxprenolol, adenylate cyclase inhibitor, 203
P
Pentobarbital, 263, 581
Pentylenepetrazol, 581
Pfeiffer’s rule, molecular basis, 598
Phenobarbital, 263, 731, 759, 820
and RNA methylation, 820
Phentolamine, 546, 862
Phenylephrine, 251, 688
and guanosine 3’ ,5’-monophosphate, 862
Phosphodiesterase activator, in lung, 678
Phosphodiesterase inhibitor, 900
Phospholipase A, C, and D, effect on f3-adrenergic
receptor, 559
Phospholipid, interaction with barbiturates, 263
Photoaffinity labelling, acetylcholinesterase, 958
Pimozide, 251, 581
Piprodol, 581
Plasma proteins, binding specificity, 612
Poly(7-deazainosinic acid), antiviral activity, 1045
Polyguanylic acid, murine leukemia virus inhibitor,
844
Polyinosinic acid, polycytidylic acid duplex, biologi-
cal properties, 299, 440
Polyribonucleotides, as inhibitors of munine leuke-
mia virus, 234
Polynibosomes breakdown, by Bruceantin, 167
Polyxanthylic acid, murine leukemia virus inhibi-
tor, 844
Potassium,
depolarizing synaptosomes, 1082
and parotid gland, 862
Procaine, on rat diaphragm muscle, 82
Promethazine, 581
Propranolol, 546, 862
effect on brain synaptosome membranes, 115
Prostaglandin E � , and /3-adrenergic receptor, 409
Protein kinase,
activation by adenosine 3,5’-monophosphate when
adrenal medulla is stimulated by canbamyl-
choline, 420
dissociation of catalytic subunits by adenosine
3’,S’-monophosphate, 420
in liver fluke, 59
in rat liver, 871
Protein sulfhydryls, and oxidation of bound cate-
cholamines, 887
Protein synthesis, and Bruceantin, 167
Protoveratrine, 251Protriptyline, 581
R
Ribosomes, reticulocyte and Bruceantin, 167
RNA biosynthesis, regulation in rat adrenal me-
dulla, 514
RNA methylation, 820
RNA Methyltransferase, induction by phenobarbi-tal, 820
RNA polymerase,distamycin on template activity, 185
SUBJECT INDEX 1119
nuclear, 731
nucleolar, 820
RNA polymerase I, activation, 871RNA polymerase II, in adrenal medulla, 514Rotenone, ethanol metabolism in liver, 156
S
Serotonin,
binding to D-lysergic acid diethylamide receptor,
620
binding to rat brain membranes, 373
uptake by synaptosomes, 1082
Sodium channel, effect of batrachotoxin and tetrodo-
toxin, 82Sodium channels, in epithelium, 945
Spin-labeled lipid vesicles, effect of anesthetics and
pressure, 127Spiroperidol, 251Structure activity relationship,
4’(9-acnidinylamino)methanesulfonanilide, 1027
and f3-adrenergic receptor, 16and dopamine and /3-adrenergic sensitive adenyl-
ate cyclase, 854
and dopamine sensitive adenylate cyclase, 251angiotensin II, 217
1,4-benzodiazepines, 612
bruceantin, 167
phenoxypropionic acid, 598
polynibonucleotides on antiviral activity, 1045
serotonin on fluke motility, 49
�9-tetrahydrocannabinol, 345
vasopressin, 313
vitamin D3 metabolites, 879
Sulfanilamide, and carbonic anhydrase, 832
Superoxide anion, catechol oxidation, 911
Superoxide dismutase, 911
Synaptic vesicles, from guinea pig cerebral cortex,778
Synaptosome, sodium dependent choline uptake,
1082
T
Temperature, effect on opiate receptor binding ac-
tivity, 977
Tetrahydrobiopterin, 1070
Tetrahydrocannabinol, effect on seratonin uptake
by synaptosomes, 345
Tetrahydrofurosemide, 759
Tetrahydroisoquinolines, effectors of adenylate cy-
clase, 854
2,2,6,6-Tetramethylpiperidine-1-oxyl, nerve con-
ductance, 136
Tetrodotoxin, on rat diaphragm muscle, 82
Thioridazine, 581
a-Toxin, interaction with cholinergic receptor, 1091
Triamterene, 945
Trifluoperazine, 546, 581, 778
a-Tubocurarine, binding to acetylcholine receptor,
999
Tubulin, binding of chlorpromazine, 769
Tyrosine aminotransferase,induction, 720
Tyrosine hydroxylase, 514
and electrical stimulation of dopaminergic neu-
rons, 1070
in dopaminergic neurons, 251, 463
induction by carbamylcholine in adrenal medulla,
420
induction in sympathetic ganglia, 353
neuronal enzyme activated by calcium chelator,
41
Tyrosine 3-monooxygenase, see Tyrosine Hydroxy!-
ase
Veratnidine, 900, 1082
V
X
Xanthine oxidase, 911
X-Ray crystal structure, of acetyicholine analogue,
590